Skip to main content
logo
Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.7242
-0.0874 (-10.77%)
At close: Oct 7, 2026, 4:00 PM EDT
0.7908
+0.0666 (9.20%)
Pre-market: Oct 8, 2026, 4:00 AM EDT

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
17142155--
Market Cap Growth
-89.13%-8.51%---
Enterprise Value
13125142--
Last Close Price
0.726.127.96--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
17.5817.951492.25--
P/TBV Ratio
17.5817.951492.25--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Debt / Equity Ratio
-4.47-1.66-82.940.66-1.31
Quick Ratio
1.162.310.980.434.71
Current Ratio
1.252.391.050.434.71
Return on Equity (ROE)
--553.75%--442.40%-
Return on Assets (ROA)
-213.40%-120.40%-255.41%-132.96%-
Return on Capital Employed (ROCE)
-1490.00%-270.10%-4876.60%636.30%-125.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-117.61%-15.63%-17.55%--
Buyback Yield / Dilution
-32.81%-151.07%-483.48%-18.54%-
SEC Filings: 10-K · 10-Q